⌘K

Home/Filings/4/0001209191-21-034027

4//SEC Filing

Baffa Raffaele 4

Accession 0001209191-21-034027

CIK 0001107421other

View on SEC.gov Company Profile

Filed

May 18, 8:00 PM ET

Accepted

May 19, 4:55 PM ET

Size

4.9 KB

Accession

0001209191-21-034027

Insider Transaction Report

Form 4

Period: 2021-05-17

ZIOPHARM ONCOLOGY INCZIOP

Chief Medical Officer

Transactions

Award
Common Stock
2021-05-17+80,645→ 280,645 total

Footnotes (1)

[F1]One-third of the shares vest on each of September 1, 2021, February 1, 2022 and May 1, 2022, subject to the Reporting Person's continued service through each such date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

Entity typeother

Related Parties

1

filerCIK 0001853684

Filing Metadata

Form type: 4
Filed: May 18, 8:00 PM ET
Accepted: May 19, 4:55 PM ET
Size: 4.9 KB

View on SEC.gov